On Jun. 23, 2020, Sanofi and Translate Bio announced they had agreed to expand their existing 2018 collaboration and license agreement to develop mRNA vaccines for infectious diseases. Under this agreement Sanofi Pasteur will receive exclusive worldwide rights for infectious disease vaccines.